Adipose browning response to burn trauma is impaired with aging.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
23 08 2021
Historique:
received: 18 08 2020
accepted: 01 07 2021
entrez: 23 8 2021
pubmed: 24 8 2021
medline: 26 2 2022
Statut: epublish

Résumé

BACKGROUNDThe incidence of burn injuries in older patients is dramatically increasing as the population of older people grows. Despite the increased demand for elderly burn care, the mechanisms that mediate increased morbidity and mortality in older trauma patients are unknown. We recently showed that a burn injury invokes white adipose tissue browning that leads to a substantially increased hypermetabolic response associated with poor outcomes. Therefore, the aim of this study was to determine the effect of age on the metabolic adipose response of browning after a burn injury.METHODOne hundred and seventy patients with burn injury admitted to the Ross Tilley Burn Centre were prospectively enrolled and grouped by age as older (≥50 years) and young (≤35 years). Adipose tissue and sera were collected and analyzed for browning markers and metabolic state via histology, gene expression, and resting energy expenditure assays.RESULTSWe found that older patients with burn injury lacked the adipose browning response, as they showed significant reductions in uncoupling protein 1 (UCP1) expression. This failure of the browning response was associated with reduced whole-body metabolism and decreased survival in older patients with burn injury. Mechanistically, we found that the adipose of both aged patients after burn trauma and aged mice after a burn showed impairments in macrophage infiltration and IL-6, key immunological regulators of the browning process after a severe trauma.CONCLUSIONTargeting pathways that activate the browning response represents a potential therapeutic approach to improve outcomes after burn trauma for elderly patients.FUNDINGNIH (R01-GM087285-01), Canadian Institutes of Health Research (grant no. 123336), and Canada Foundation for Innovation Leaders Opportunity Fund (no. 25407).

Identifiants

pubmed: 34423787
pii: e143451
doi: 10.1172/jci.insight.143451
pmc: PMC8409980
doi:
pii:

Substances chimiques

UCP1 protein, human 0
Uncoupling Protein 1 0

Types de publication

Journal Article Observational Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM087285
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM133961
Pays : United States
Organisme : CIHR
ID : 123336
Pays : Canada

Références

Cell Mol Life Sci. 2014 Sep;71(17):3241-55
pubmed: 24714880
Int J Exp Pathol. 2017 Apr;98(2):100-108
pubmed: 28543963
J Clin Invest. 2015 Feb;125(2):478-86
pubmed: 25642708
Cell Metab. 2017 Feb 7;25(2):481
pubmed: 28178569
World J Crit Care Med. 2017 May 4;6(2):99-106
pubmed: 28529911
Diabetes. 2016 May;65(5):1179-89
pubmed: 26718499
Obes Res Clin Pract. 2013 Dec;7(6):e432-8
pubmed: 24459687
Eur J Clin Nutr. 2000 Jun;54 Suppl 3:S77-91
pubmed: 11041079
Endocr Rev. 2017 Dec 1;38(6):538-549
pubmed: 28938469
Nature. 2014 Sep 4;513(7516):100-4
pubmed: 25043053
Trends Endocrinol Metab. 2016 Aug;27(8):542-552
pubmed: 27397607
J Trauma. 2000 Jan;48(1):49-56; discussion 56-7
pubmed: 10647565
Crit Care Med. 2019 Feb;47(2):201-209
pubmed: 30371519
J Burn Care Res. 2020 Jan 30;41(1):65-83
pubmed: 31999337
Cell Metab. 2015 Aug 4;22(2):219-27
pubmed: 26244931
Biochim Biophys Acta Mol Basis Dis. 2017 Nov;1863(11):2705-2714
pubmed: 28711594
Diabetes Metab J. 2013 Feb;37(1):22-9
pubmed: 23441053
Am J Physiol Endocrinol Metab. 2010 Jun;298(6):E1244-53
pubmed: 20354155
Int J Obes (Lond). 2014 Jun;38(6):812-7
pubmed: 24213309
Cell Death Dis. 2019 Nov 18;10(12):870
pubmed: 31740668
Cell Metab. 2014 Sep 2;20(3):433-47
pubmed: 25043816
J Clin Invest. 2012 Mar;122(3):1022-36
pubmed: 22307324
Cell. 2014 Jun 5;157(6):1292-1308
pubmed: 24906148
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jan;1864(1):91-103
pubmed: 29859245
Mol Metab. 2018 Feb;8:65-76
pubmed: 29237539
Cell Metab. 2016 Sep 13;24(3):434-446
pubmed: 27568549
Injury. 2021 Apr;52(4):757-766
pubmed: 33069394
EBioMedicine. 2015 Jul 31;2(10):1536-48
pubmed: 26629550
Ageing Res Rev. 2010 Jan;9(1):1-11
pubmed: 19698803
Shock. 2017 Jan;47(1):33-39
pubmed: 27648696
Diabetes. 2012 Jun;61(6):1315-22
pubmed: 22618766
Aging Clin Exp Res. 2016 Jun;28(3):579-81
pubmed: 27106900
Burns Trauma. 2020 Oct 22;8:tkaa027
pubmed: 33123606
Ann Surg. 2019 Mar;269(3):554-563
pubmed: 28817438
Aging Cell. 2019 Dec;18(6):e13048
pubmed: 31560163
J Trauma. 1999 Apr;46(4):702-6
pubmed: 10217237
J Orthop Trauma. 2012 Sep;26(9):e161-5
pubmed: 22377505
Cell Rep. 2015 Nov 24;13(8):1538-44
pubmed: 26586436
Cell. 2015 Jan 15;160(1-2):74-87
pubmed: 25543153

Auteurs

Abdikarim Abdullahi (A)

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Carly M Knuth (CM)

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Christopher Auger (C)

Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Thibacg Sivayoganathan (T)

Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Alexandra Parousis (A)

Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Marc G Jeschke (MG)

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
Ross Tilley Burn Centre, Sunnybrook Hospital, Toronto, Ontario, Canada.
Department of Surgery, Division of Plastic Surgery, and Department of Immunology, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH